ReproCELL: Extraordinary Report
ReproCELL: Notice regarding differences between full-year individual results for the fiscal year ending March 31, 2024 and results for the previous fiscal year
ReproCELL: Summary of Financial Results for the Fiscal Year Ending March 31, 2024 [Japanese GAAP] (Consolidated)
ReproCELL: Notice regarding the recording of non-operating income, extraordinary loss, and revisions to the full-year consolidated earnings forecast for the fiscal year ending March 31, 2024
Reprocess: Confirmation
Reprocel: Quarterly Report - 22nd Quarter 3rd Quarter (2023/10/01 to 2023/12/31)
ReproCELL: Summary of Financial Results for the 3rd Quarter of the Fiscal Year Ending March 31, 2024 [Japanese GAAP] (Consolidated)
ReproCELL: Quarterly Report - 22nd Second Quarter (2023/07/01 - 2023/09/30)
ReproCELL: Confirmation letter
ReproCELL: Summary of Financial Results for the 2nd Quarter of the Fiscal Year Ending March 31, 2024 [Japanese GAAP] (Consolidated)
ReproCELL: Confirmation letter
ReproCELL: Quarterly Report - First Quarter 22nd (2023/04/01 - 2023/06/30)
ReproCELL: Summary of Financial Results for the 1st Quarter of the Fiscal Year Ending March 31, 2024 [Japanese GAAP] (Consolidated)
ReproCELL Incorp: Confirmation letter
ReproCELL Incorp: Securities Report - 21st Period (2022/04/01 - 2023/03/31)
ReproCELL Incorp: Summary of Financial Results for the Fiscal Year Ending March 2023 [Japanese GAAP] (Consolidated)
ReproCELL Incorp: Notice regarding the difference between the full-year individual results for the fiscal year ending March 2023 and the previous fiscal year
ReproCELL Incorp: Notice regarding recording of inventory valuation losses (cost of sales), non-operating income, non-operating expenses, and extraordinary losses, and revisions to full-year consolidated earnings forecasts for the fiscal year ending March
ReproCELL Incorp: Quarterly report-21st quarter third quarter (2022-10-01-2022-12-31)
ReproCELL Incorp: Confirmation letter
No Data